Ibex
Clinical-grade AI pathology for cancer detection, grading, quality control, and connected laboratory workflows.
About Ibex
Ibex is a clinical-grade, multi-tissue AI pathology platform developed for pathologists. It supports detection and grading of breast, prostate, and gastric cancer, as well as more than one hundred other clinically relevant features. The platform fits into digital pathology workflows through integrations with third-party software, slide-scanning platforms, laboratory information systems, and an open API. It provides automated diagnostic insights that can help pathologists review cases faster, reduce workload, and add prospective quality control. Before adoption, teams need to review compatibility, regulation, and procurement: availability and approved indications vary by market, some United States solutions are for research use only and are not FDA-cleared, and public list pricing is not offered. Ibex reports training its algorithms on datasets drawn from more than 10 million slides and lists healthcare-focused compliance frameworks and certifications in its trust center.
Best for
Best use cases
Adding AI-assisted detection and grading to routine slide review
Introducing prospective quality control for high-volume pathology work
Connecting pathology AI to scanners and laboratory information systems
Compare before choosing
Compare supported tissue types and approved indications in your region
Assess compatibility with current scanners, software, and laboratory systems
Request a commercial quote and account for validation and rollout work
Features
Cancer detection and grading
Support pathologists reviewing breast, prostate, and gastric cases with automated detection, grading, and diagnostic feature analysis.
Prospective quality control
Add an AI review layer that can draw attention to small or higher-grade cancer foci during routine diagnostic work.
Digital pathology workflow integration
Connect AI analysis with scanners, digital pathology applications, and laboratory information systems used by healthcare providers.
Pros
- Multi-tissue analysis supports several cancer workflows within one pathology platform.
- Connections to scanners, pathology software, laboratory systems, and an open API reduce workflow fragmentation.
- Healthcare compliance coverage and clinical studies provide concrete material for trust and governance reviews.
Cons
- Quote-based pricing makes early cost comparison and budget planning less direct.
- Deployment depends on compatible digital pathology systems, scanners, and laboratory integration work.
- Regulatory availability varies by country, and some United States solutions are research-use-only and not FDA-cleared.
Pricing Plans
Enterprise
- Clinical-grade multi-tissue AI pathology platform
- Workflow and systems integration
- Deployment and regulatory scoping with Ibex
* Pricing information is for reference only. Please refer to the latest announcement on Ibex's official website.